
Guangdong True Health Medical Technology Development Co., Ltd.
2697.HKHKSEHealthcareMedical - Devices
最新資料
HK$759
+HK$91.00 · +13.62%
2697.HK公司概覽
盤中時間採用HKT。市場資料可能有所延遲。
公司概況
公司網站Guangdong True Health Medical Technology Development Co., Ltd. engages in in the research and development, manufacture and sale of surgical robots and disposables in the People's Republic of China and Hong Kong. The company offers products, such as percutaneous puncture surgery robots, includes TH-S1, TH-S, TH-S Pro and TH-SA; microwave ablation surgical robot for the treatment of liver and lung tumors; percutaneous microwave ablation surgical robot TH-X HMW approved for the treatment of liver tumors; AI-based 3D reconstruction software for medical imaging; and five additional product, including the TH-P series of compact percutaneous puncture surgical robots which are approved for lung and abdominal puncture, the MW150 microwave ablation device, the TH-X Cryo cryoablation robot, the TH-LS KI300 and TH-LS LU100 ex vivo organ preservation and assessment systems. The company was formerly known as True Health (Guangdong Hengqin) Medical Technology Co., Ltd. and changed its name to Guangdong True Health Medical Technology Development Co., Ltd. in October 2025. The company was incorporated in 2018 and is based in Zhuhai, China.
- 產業
- Medical - Devices
- 部門
- Healthcare
- 總部
- CN
- 執行長
- Hou Iam Cheong
- 上市以來
- 2026年6月30日
- 僱員
- 156
市場位置
日內區間
目前HK$759,
52週區間
目前HK$759,
- 開盤價
- HK$668
- 前收盤價
- HK$668
- 成交量
- 4.82萬
- 0.7× 平均值
- 平均成交量
- 6.92萬
- 日均成交量
- 市值
- 270.56億 HKD
- 貝塔
- -0.9
- 市場參考 1
- 50天平均值
- HK$595.88
- 高於平均水平+27.37%
- 200天平均值
- HK$595.88
- 高於平均水平+27.37%
2697.HK同業公司
繼續GoAI的研究
在 GoAI 中研究2697.HKresearch.disclaimer





